Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,998 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Red Cell Transfusion Goals in Patients With Acute Leukemias

NCT02086773

Conditions: Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia (ALL), Acute Myelogenous Leukemia (AML), +15 more
Locations: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

NCT02208037

Conditions: Acute Leukemia, Anemia, Anemia, Refractory, +35 more
Locations: City of Hope National Medical Center Duarte, California, United States

Stanford Hospital and Clinics Stanford, California, United States

University of Florida College of Medicine (Shands) Gainesville, Florida, United States

H. Lee Moffitt Cancer Center Tampa, Florida, United States

View all 30 locations

View Trial Details

Completed

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

NCT02908347

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +25 more
Locations: Rothaar Studien GmbH Berlin, Germany

PAREXEL International GmbH, Klinikum Westend Berlin, Germany

Klinische Forschung Dresden GmbH Dresden, Germany

Gemeinschaftspraxis Prof. Dr. Vanscheidt und Dr. Ukat Freiburg im Breisgau, Germany

View Trial Details

Completed

Reduced Intensity Double Umbilical Cord Blood Transplantation

NCT01408563

Conditions: Acute Myelogenous Leukemia, Anemia, Anemia, Aplastic, +34 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01093586

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +141 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies.

NCT01715623

Conditions: Children With HSP, Healthy Volunteers, Hemic and Lymphatic Diseases, +8 more
Locations: Clinical Investigation Center Limoges, France

Nephrology Limoges, France

Pediatric Limoges, France

Pneumology Limoges, France

View Trial Details

Completed

Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis

NCT01582932

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: Investigational Site Birmingham, Alabama, United States

Investigational Site Rogers, Arkansas, United States

Investigational Site Encino, California, United States

Fountain Valley, California, United States

View all 36 locations

View Trial Details

Completed

Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides

NCT00103246

Conditions: Carcinoma, Carcinoma, Basal Cell, Hemic and Lymphatic Diseases, +23 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to Therapy

NCT00727415

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Unità Operativa Ematologia 1 - Università degli Studi di Bari Bari, Italy

Istituto di Ematologia e Oncologia Medica "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy

Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Italy

Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Ferrara, Italy

View all 23 locations

View Trial Details

Completed

FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma

NCT00530179

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

Ottawa General Hospital Ottawa, Ontario, Canada

Saskatchewan Cancer Agency Regina, Saskatchewan, Canada

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions